Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Feb:134:111143.
doi: 10.1016/j.biopha.2020.111143. Epub 2020 Dec 16.

Could natural products modulate early inflammatory responses, preventing acute respiratory distress syndrome in COVID-19-confirmed patients?

Lucas Amaral-Machado  1 , Wógenes N Oliveira  2 , Victor M Rodrigues  2 , Nathan A Albuquerque  2 , Éverton N Alencar  1 , Eryvaldo S T Egito  3
Affiliations
Review

Could natural products modulate early inflammatory responses, preventing acute respiratory distress syndrome in COVID-19-confirmed patients?

Lucas Amaral-Machado et al. Biomed Pharmacother. 2021 Feb.

Abstract

Background: The ARDS (Acute Respiratory Distress Syndrome) is a severe respiratory syndrome that was recently associated as the main death cause in the COVID-19 pandemic outbreak. Hence, in order to prevent ARDS, the pulmonary function maintenance has been the target of several pharmacological approaches. However, there is a lack of reports regarding the use of effective pharmaceutical active natural products (PANPs) for early treatment and prevention of COVID-19-related ARDS. Therefore, the aim of this work was to conduct a systematic review regarding the PANPs that could be further studied as alternatives to prevent ARDS. Consequently, this work can pave the way to spread the use of PANPs on the prevention of ARDS in COVID-19-confirmed or -suspected patients.

Methods: The search strategy included scientific studies published in English from 2015 to 2020 that promoted the elucidation of anti-inflammatory pathways targeting ARDS by in vitro and/or in vivo experiments using PANPs. Then, 74 studies regarding PANPs, able to maintain or improve the pulmonary function, were reported.

Conclusions: The PANPs may present different pulmonary anti-inflammatory pathways, wherein (i) reduction/attenuation of pro-inflammatory cytokines, (ii) increase of the anti-inflammatory mediators' levels, (iii) pulmonary edema inhibition and (iv) attenuation of lung injury were the most observed biological effects of such products in in vitro experiments or in clinical studies. Finally, this work highlighted the PANPs with promising potential to be used on respiratory syndromes, allowing their possible use as alternative treatment at the prevention of ARDS in COVID-19-infected or -suspected patients.

Keywords: ARDS prevention; COVID-19; Immunomodulation; Natural products.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

None
Graphical abstract
Scheme 1
Scheme 1
Flowchart of the manuscripts’ evaluation after the performed search strategy.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Bi Q., Wu Y., Mei S., Ye C., Zou X., Zhang Z., Liu X., Wei L., Truelove S.A., Zhang T., Gao W., Cheng C., Tang X., Wu X., Wu Y., Sun B., Huang S., Sun Y., Zhang J., Ma T., Lessler J., Feng T. Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study. Lancet Infect. Dis. 2020;20(8):911–919. - PMC - PubMed
    1. Allam Z. The second 50 days: a detailed chronological timeline and extensive review of literature documenting the COVID-19 pandemic from day 50 to day 100. Surveying the Covid-19 Pandemic its Implications. 2020:9–39.
    1. Marson F.A.L. COVID-19–6 million cases worldwide and an overview of the diagnosis in Brazil: a tragedy to be announced. Diagn Microbiol Infec Dis. 2020;98(2) - PMC - PubMed
    1. Monteleone G., Sarzi-Puttini P.C., Ardizzone S. Preventing COVID-19-induced pneumonia with anticytokine therapy. Lancet Rheumatol. 2020;2(5):E255–E256. - PMC - PubMed
    1. Siddiqi H.K., Mehra M. COVID-19 illness in native and immunosuppressed states: a clinical–therapeutic staging proposal. J. Heart Lung Transplant. 2020;39(5):405–407. - PMC - PubMed

MeSH terms

LinkOut - more resources